An Integrated Care Model for Pregnant and Postpartum Individuals Receiving Medication for Opioid Use Disorder

被引:15
|
作者
Ellis, Laura Peyton [1 ]
Parlier-Ahmad, Anna Beth [2 ]
Scheikl, Marjorie [3 ,4 ]
Martin, Caitlin E. [3 ,4 ,5 ]
机构
[1] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA
[2] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA USA
[3] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA USA
[4] Virginia Commonwealth Univ, Inst Drug & Alcohol Studies, Richmond, VA USA
[5] 1101 East Marshall St,11th Floor,Room 11-027,Box 9, Richmond, VA 23298 USA
关键词
addiction; integrated care; opioid use disorder; postpartum; pregnancy; ASSISTED TREATMENT; WOMEN; DEPENDENCE; RETENTION; OUTCOMES;
D O I
10.1097/ADM.0000000000001052
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
ObjectivesPerinatal opioid use disorder is increasing. Integrated obstetric/addiction care models likely optimize parent-infant dyad outcomes, but the ideal combination of services is unknown. This study (1) describes pregnancy-to-postpartum service utilization by people receiving buprenorphine at an integrated Obstetric/Addiction Clinic and (2) explores the association between service utilization and postpartum buprenorphine continuation.MethodsThis retrospective medical record review study uses research registry data from an outpatient Obstetric/Addiction Clinic. All patients are invited to participate in the research registry. For patients who consent, monthly medical record abstractions are conducted beginning with their first clinic visit to collect demographic, obstetric, and substance use disorder treatment variables. Present analyses included patients who delivered an infant between June 2019 and June 2021, started buprenorphine during pregnancy, and were receiving buprenorphine at delivery. Overall service utilization was the number of services (range 0-12) used between 28-weeks gestation and 12-weeks postpartum. Bivariate analyses and multivariable logistic regression assessed associations between service utilization and buprenorphine continuation.ResultsParticipants (n = 42) were primarily non-Latinx White (67%) with comorbid psychiatric diagnoses (95%). On average, participants used 6 services; prenatal care, mental health care, and postpartum contraception were most utilized. Overall, 69% of participants continued buprenorphine at 6 months postpartum. This did not differ by level of service utilization (bivariate [P = 0.07], multivariable [P = 0.16]).ConclusionIntegrated care with a harm reduction focus supports pregnancy-to-postpartum service utilization and buprenorphine continuation in a patient sample at high risk for medication for opioid use disorder discontinuation. Further work is needed to identify evidence-based methods to individualize integrated obstetric/addiction care.
引用
收藏
页码:131 / 139
页数:9
相关论文
共 50 条
  • [1] Medication for Addiction Treatment and Postpartum Health Care Utilization Among Pregnant Persons With Opioid Use Disorder
    Ahrens, Katherine A.
    McBride, Carole A.
    O'Connor, Alane
    Meyer, Marjorie C.
    JOURNAL OF ADDICTION MEDICINE, 2022, 16 (01) : 56 - 64
  • [2] Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder
    Wilder, Christine
    Lewis, Daniel
    Winhusen, Theresa
    DRUG AND ALCOHOL DEPENDENCE, 2015, 149 : 225 - 231
  • [3] Stigmatization of Pregnant Individuals with Opioid Use Disorder
    Crawford, Allison D.
    McGlothen-Bell, Kelly
    Recto, Pamela
    McGrath, Jacqueline M.
    Scott, Leticia
    Brownell, Elizabeth A.
    Cleveland, Lisa M.
    WOMENS HEALTH REPORTS, 2022, 3 (01): : 172 - 179
  • [4] Availability of Medications for the Treatment of Opioid Use Disorder Among Pregnant and Postpartum Individuals in US Jails
    Sufrin, Carolyn
    Kramer, Camille T.
    Terplan, Mishka
    Fiscella, Kevin
    Olson, Sarah
    Voegtline, Kristin
    Latkin, Carl
    JAMA NETWORK OPEN, 2022, 5 (01)
  • [5] Quality of primary care among individuals receiving treatment for opioid use disorder
    Spithoff, Sheryl
    Kiran, Tara
    Khuu, Wayne
    Kahan, Meldon
    Guan, Qi
    Tadrous, Mina
    Leece, Pamela
    Martins, Diana
    Gomes, Tara
    CANADIAN FAMILY PHYSICIAN, 2019, 65 (05) : 343 - 351
  • [6] SLEEP ARCHITECTURE IN INDIVIDUALS RECEIVING METHADONE FOR MEDICATION-ASSISTED TREATMENT OF OPIOID USE DISORDER
    Erwin, J. A.
    Wilson, M.
    Finlay, M.
    Hansen, D. A.
    Little-Gott, A.
    Reynolds, D.
    Quock, R. M.
    Layton, M. E.
    Van Dongen, H.
    SLEEP, 2020, 43 : A394 - A395
  • [7] Attitudes Toward Medication for Opioid Use Disorder Among Pregnant and Postpartum Women and People Seeking Treatment
    Banks, Devin E.
    Fentem, Andrea
    Li, Xiao
    Paschke, Maria
    Filiatreau, Lindsey
    Woolfolk, Candice
    Cavazos-Rehg, Patricia
    JOURNAL OF ADDICTION MEDICINE, 2023, 17 (03) : 356 - 359
  • [8] Perspectives of the Obstetric Care Environment for Pregnant Individuals Who Have an Opioid Use Disorder
    Girasulo, Samantha
    Maltz, Caro
    Weichert, Maggie
    Kaufman, Joy S.
    Mele, Amanda
    Hunkele, Karen
    Yonkers, Kimberly A.
    Byatt, Nancy
    Forray, Ariadna
    WOMENS HEALTH REPORTS, 2025, 6 (01): : 155 - 160
  • [9] The primary care behavioral health model (PCBH) and Medication for opioid use disorder (MOUD): Integrated models for primary care
    Zerden, Lisa de Saxe
    Cooper, Zachary
    Sanii, Hannah
    SOCIAL WORK IN MENTAL HEALTH, 2022, 20 (02) : 149 - 158
  • [10] The primary care behavioral health model (PCBH) and medication for opioid use disorder (MOUD): integrated models for primary care
    Zerden, Lisa de Saxe
    Cooper, Zachary
    Sanii, Hannah
    SOCIAL WORK IN MENTAL HEALTH, 2021, 19 (02) : 186 - 195